Pingli Wang

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Topics

Randomized Controlled Trial

Top Venues

The clinical respiratory journal

Discover oncology

Journal of immunology research

Cancer communications (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaojie Huang, Guanchao Pang, Zhirong Mao, Baizhou Li, Zhihua Teng, Yan Yang, Zijian Qiu, Xiuxiu Chen, Pingli Wang
Clinical outcomes associated with neoadjuvant therapy for the treatment of resectable non-small cell lung cancer in real-world practice. The clinical respiratory journal 18 (5) (2024)
Zijian Qiu, Guanchao Pang, Xia Xu, Jun Lin, Pingli Wang
Characteristics of mast cell infiltration in lung adenocarcinoma and its impact on prognosis. Discover oncology 15 (1) (2024)
Xiaojie Huang, Guanchao Pang, Zhirong Mao, Baizhou Li, Zhihua Teng, Yan Yang, Zijian Qiu, Xiuxiu Chen, Pingli Wang
Clinical outcomes associated with neoadjuvant therapy for the treatment of resectable non-small cell lung cancer in real-world practice. The clinical respiratory journal 18 (5) (2024)
Zijian Qiu, Guanchao Pang, Xia Xu, Jun Lin, Pingli Wang
Characteristics of mast cell infiltration in lung adenocarcinoma and its impact on prognosis. Discover oncology 15 (1) (2024)
Pingli Wang, Liming Cao, Panwen Tian, Shengxiang Ren, Liyun Miao, Chengzhi Zhou, Yun Fan, Yuping Li, Dongqing Lv, Xin Zhao, Mei Yang, Chaonan Zhu, Bing Yu, June Xu, Yong Song, Kai Wang
A phase II study on Mefatinib as first-line treatment of patients with advanced non-small-cell lung cancer harboring uncommon EGFR mutations. Cancer communications (London, England) (2023)
Chengyan Zhang, Guanchao Pang, Chengxi Ma, Jingni Wu, Pingli Wang, Kai Wang
Preoperative Risk Assessment of Lymph Node Metastasis in cT1 Lung Cancer: A Retrospective Study from Eastern China. Journal of immunology research 2019 (2019)